A Global Epidemic of Multiple Sclerosis?

Authors: M. Vachová
Authors‘ workplace: MS centrum při neurologickém oddělení ;  Krajská zdravotní, a. s. – Nemocnice Teplice, o. z.
Published in: Cesk Slov Neurol N 2012; 75/108(6): 701-706
Category: Review Article


Multiple sclerosis as a life-long chronic disease is at the centre of interest of many epidemiological studies. The increasing prevalence of this disease is frequently associated with increased incidence. The cause of elevation is different in different populations. The first explanation is an improved diagnostic process. Acceleration is also possible due to changed diagnostic criteria. The article presents various types of epidemiological surveys and provides an overview of prevalence and incidence of MS in various parts of the world. The last Czech data published at the beginning of 1990th showed the prevalence at the Teplice district to be 130.5/100,000. No new epidemiological survey has been performed since. The data currently available suggest a prevalence in the Czech Republic of 160/100,000.

Key words:
multiple sclerosis – epidemiology – prevalence – incidence – risk factors – disease registry


1. Brønnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish pa­tients with multiple sclerosis. Brain 2004; 127 (Pt 4): 844–850.

2. Koch-Henriksen N. The Danish Multiple Sclerosis Registry: a 50-year follow-up. Mult Scler 1999; 5(4): 293–296.

3. Koch-Henriksen N, Brønnum-Hansen H, Hyllested K. Incidence of multiple sclerosis in Denmark 1948––1982: a descriptive nationwide study. Neuroepide­miology 1992; 11(1): 1–10.

4. Bramwell B. The prognosis in disseminated sclerosis; duration in two hundred cases of disseminated sclerosis. Edinb Med J 1917; 18: 15–23.

5. Compston A, Confavreux C. The distribution of multiple sclerosis. In: Compston A, Confavreux C, Lassmann H et al (eds). Mc Alpine’s Multiple Sclerosis. 4th ed. London: Churchill Livingstone Elsevier 2006: 71–111.

6. Kurtzke JF. A reassessment of the distribution of multiple sclerosis. Acta Neurol Scand 1975; 51(2): 110–157.

7. World Health Organisation, Multiple sclerosis International Federation [on-line]. Atlas Multiple sclerosis resources in the world 2008. Available from: http://www.msif.org/atlasofms.

8. Sutherland JM. Observations on the prevalence of multiple sclerosis in Northern Scotland. Brain 1956; 79(4): 635–654.

9. Reder A, Goodin G, Ebers G, Cuttler G, Kremenchutzky M, Oger J et al. Clinical outcomes for interferon-beta-1b versus placebo, 21 years following randomisation. ECTRIMS 2011 Oct 19.–22. Amsterodam, Netherlands. Long-term treatment monitoring: P514.

10. Kruja J, Kuqo A, Mijo S, Zekja I, Bala J, Grabova S et al. Prevalence of multiple sclerosis in Albania. ECTRIMS 2010 Oct 13–16. Goteborg, Sweden. Epide­miology 1: P189.

11. al Rajeh S, Bademosi O, Ismail H, Awada A, Dawodu A, al-Freihi H et al. A community survey of neurological disorders in Saudi Arabia: the Thugbah study. Neuroepidemiology 1993; 12(3): 164–178.

12. Baumhackl U, Eibl G, Ganzinger U, Hartung HP, Mamoli B, Pfeiffer KP et al. Prevalence of multiple sclerosis in Austria. Result of nationwide survey. Neuroepidemiology 2002; 21(5): 226–234.

13. Vukusic S, Van Bockstael V, Gosselin S, Confavreux C. Regional variations in the prevalence of multiple sclerosis in French farmers. J Neurol Neurosurg Psychiatry 2007; 78(7): 707–709.

14. Fromont A, Binquet C, Sauleau EA, Fournel I, Bellisario A, Adnet J et al. Geographic variations of multiple sclerosis in France. Brain 2010; 133 (Pt 7): 1889–1899.

15. Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vécsei L et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006; 13(7): 700–722.

16. Bentzen J, Flachs EM, Stenager E, Brønnum-Hansen H, Koch-Henriksen N. Prevalence of multiple sclerosis in Denmark 1950–2005. Mult Scler 2010; 16(5): 520–525.

17. Koch-Henriksen N, Rasmussen S, Stenager E, Madsen M. The Danish Multiple Sclerosis Registry: history, data collection, and validity. Dan Med Bull 2001; 48(2): 91–94.

18. Lycke K, Alfredsson L, Olsson T, Hillert J. From patient registry to Biobank – high participation in a nationwide survey of genes and enviroment in multile sclerosis (GEMS study). ECTRIMS 2010. Oct 13.–16. Goteborg, Sweden. Epidemiology 2: P631.

19. Ahlgren C, Odén A, Lycje J. High prevalence of multiple sclerosis in Sweden. Swedish Multiple Sclerosis Registry. ECTRIMS 2010. Oct 13.–16. Goteborg, Sweden. Epidemiology 1: P187.

20. Moreau T, Manceau E, Lucas B, Lemesle M, Urbinelli R, Giroud M. Incidence of multiple sclerosis in Dijon, France a population based ascertainment. Neurol Res 2000; 22(2): 156–159.

21. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126 (Pt 4): 770–782.

22. Millefiorini E, Cortese A, Di Rezze S, Barletta G, Bellatonio P, Batocchi AP et al. The prevalence of multiple sclerosis in central Italy. Mult Scler 2010; 16(12): 1432–1436.

23. Granieri E, Malagú S, Casetta I, Tola MR, Govoni V, Paolini E et al. Multiple sclerosis in Italy. A reappraisal of incidence and prevalence in Ferrara. Arch Neurol 1996; 53(8): 793–798.

24. Granieri E, Economou NT, De Grennaro R, Tola MR, Caniatti L, Govoni V et al. Multiple sclerosis in the province of Ferrara: evidence for an increasing trend. J Neurol 2007; 254(12): 1642–1648.

25. Grimaldi LM, Palmeri B, Salemi G, Giglia G, D’Amelio M, Grimaldi R et al. High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy. Neuroepidemiology 2007; 28(1): 28–32.

26. Granieri E, Casetta I, Govoni V, Tola MR, Marchi D, Murgia SB et al. The incerasing incidence and prevalence of MS in a Sardinian Province. Neurologogy 2000; 55(6): 842–848.

27. Krökki O, Bloigu R, Reunanen M, Remes AM. Increasing incidence of multiple sclerosis in women in Nothern Finland. Mult scler 2010; 17(2): 133–138.

28. Handel AE, Jarvis L, McLaughlin R, Fries A, Ebers GC, Ramagopalan SV. The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions. PLoS One 2011; 6(1): e14606.

29. Rothwell PM, Charlton D. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998; 64(6): 730–735.

30. Cook SD, Cromarty JI Trapp W, Poskanzer D, Walker JD, Dowling PC. Declining incidencen of multiple sclerosis in the Orkney Islands. Neurology 1985; 35(4): 545–551.

31. Visser EM, Wilson JF, Wilde K, Yong KK, Counsell C. A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city. ECTRIMS 2011 Oct 19.–22. Amsterodam, Netherlands. Epidemiology 2: P700.

32. Hein T, Hopfenmüller W. Projection of the number of multiple sclerosis patients in Germany. Nervenartz 2000; 71(4): 288–294.

33. Al-Hashel J, Besterman AD, Wolfson C. The prevalence of multiple sclerosis in the Middle East. Neuroepidemiology 2008; 31(2): 129–137.

34. Taylor BV, Pearson JF, Clarke G, Mason DF, Abernethy DA, Willoughby E. MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Mult Scler 2010; 16(12): 1422–1431.

35. Barnett MH, Williams DB, Day S, Macaskill P, McLeod JG. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35 year study. J Neurol Sci 2003; 213(1–2): 1–6.

36. Noonan CW, Williamson DM, Henry JP, Indian R, Lynch SG, Neuberger JS et al. The prevalence of multiple sclerosis in 3 US communities. Prev Chronic Dis 2010; 7(1): A12.

37. Noonan CW, Kathman SJ, White MC. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002; 58(1): 136–138.

38. Jedlička P. Epidemiology of multiple sclerosis in Czechoslovakia. In: Battaglia MA, Crimi G (eds). An update on multiple sclerosis. Bologna: Monduzzi Editore 1989: 253–255.

39. Jedlička P, Benes B, Hron B et al. Epidemiology of multiple sclerosis in Czech Republic. In: Firnhaber W, Lauer K (eds). Multiple sclerosis in Europe: an epidemiological update. Darmstadt: Leuchtturm-Verlag/LTV Press 1994: 261–265.

40. Cabadaj J. K výskytu roztroušené sklerózy v okrese Teplice. Cesk Slov Neurol N 1998; 61/94(6): 321–326.

41. Havrdová E. Roztroušená skleróza mozkomíšní. In: Havrdová E et al (eds). Neuroimunologie. Praha: Maxdorf 2001: 231–263.

42. Vachová M. Současná epidemiologická data roztroušené sklerózy v ČR. Cesk Slov Neurol N 2010; 73/106 (Suppl 2): S124.

Paediatric neurology Neurosurgery Neurology

Article was published in

Czech and Slovak Neurology and Neurosurgery

Issue 6

2012 Issue 6

Most read in this issue

This topic is also in:

Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account